Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study.

Authors :: Marfella R
D'Onofrio N
Sardu C
Scisciola L
Maggi P
Coppola N
Romano C
Messina V
Turriziani F
Siniscalchi M
Maniscalco M
Boccalatte M
Napolitano G
Salemme L
Marfella LV
Basile E
Montemurro MV
Papa C
Frascaria F
Papa A
Russo F
Tirino V
Papaccio G
Galdiero M
Sasso FC
Barbieri M
Rizzo MR
Balestrieri ML
Angelillo IF
Napoli C
Paolisso G
Source :: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2022 Jan; Vol. 24 (1), pp. 160-165. Date of Electronic Publication: 2021 Oct 01.
Publication Year :: 2022

Subjects :: Blood Glucose
Glycated Hemoglobin analysis
Humans
COVID-19 prevention & control
COVID-19 Vaccines immunology
Diabetes Mellitus, Type 2
Glycemic Control
Immunogenicity, Vaccine

Full Text Access

Tools